EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Voluntis's Enterprise Value is €81.14 Mil.
Voluntis's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2021 was €-7.00 Mil. Therefore, Voluntis's EV-to-FCF for today is -11.59.
The historical rank and industry rank for Voluntis's EV-to-FCF or its related term are showing as below:
XPAR:ALVTX'
s EV-to-FCF Range Over the Past 10 Years
Min: -34.76 Med: -1.38 Max: 0.73
Current: -11.59
During the past 5 years, the highest EV-to-FCF of Voluntis was 0.73. The lowest was -34.76. And the median was -1.38.
XPAR:ALVTX's EV-to-FCF is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 18.79
vs XPAR:ALVTX: -11.59
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for Voluntis's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Voluntis's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Voluntis's EV-to-FCF Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Voluntis's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Voluntis's EV-to-FCF falls into.
Voluntis's current Enterprise Value is €81.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Voluntis's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2021 was €-7.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Voluntis (XPAR:ALVTX) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Voluntis's share price for today is €8.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Voluntis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was €-0.960.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Voluntis EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Voluntis's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:ALVTX has been successfully added to your 